Disclosures / Truffle Capital Sas , Philippe Pouletty
FR0013
AFFLUENT MEDICAL
Amount
~€5.0M
@ €2.34 / per share
Detailed Analysis
Truffle Capital Sas , Philippe Pouletty (A regulated executive) purchased ~€5.0M in AFFLUENT MEDICAL (FR0013) on XPAR on 02 Feb 2026, disclosed 3 days later. An open-market purchase with no compensation or vesting context — real personal capital committed at market prices. The discretionary nature is the primary signal here.
Price history — FR0013
Price since trade
+32.05%
SPY since trade
+6.29%
Trade date
02 February 2026
When the trade occurred
Disclosed date
04 February 2026
2-day delay
Disclosure delay: 2 days. This trade was reported to regulators 2 days after it occurred. By the time this filing became public, markets had 2 additional days to react to any non-public information.
Reference data
Use these identifiers to look up this instrument in your own platform. Disclosyr does not link to any broker.
Ticker
FR0013
ISIN
FR0013333077
Exchange
XPAR
Company
AFFLUENT MEDICAL
Filed with amf france on 04 February 2026